Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Cascinu · SciRah

Researcher profile · Semantic Scholar

S. Cascinu

Share profile

S. Cascinu — researcher profile on SciRah

h-index: 76
Works: 922
Citations: 26K

Most-cited papers

Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
F. Lordick, F. Carneiro, S. Cascinu, T. Fleitas +4 more
2022Annals of Oncology1,354 citations Open access
Semantic Scholar
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines
Martina Cavestro Giulia, A. Mannucci, F. Balaguer, H. Hampel +62 more
2022Clinical Gastroenterology and Hepatology140 citations Open access
Semantic Scholar
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population.
A. Casadei-Gardini, M. Rimini, T. Tada, G. Suda +79 more
2022European Journal of Cancer124 citations Open access
Semantic Scholar
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis
M. Rimini, L. Rimassa, K. Ueshima, V. Burgio +73 more
2022ESMO Open119 citations Open access
Semantic Scholar
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data
M. Rimini, L. Fornaro, S. Lonardi, M. Niger +36 more
2023Liver international (Print)102 citations Open access
Semantic Scholar
Lenvatinib versus sorafenib in first‐line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis
A. Casadei-Gardini, M. Scartozzi, T. Tada, C. Yoo +23 more
2021Liver international (Print)68 citations
Semantic Scholar
Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients.
M. Persano, M. Rimini, T. Tada, G. Suda +75 more
2023European Journal of Cancer54 citations Open access
Semantic Scholar
Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control study
M. Rimini, S. Shimose, S. Lonardi, T. Tada +21 more
2021Hepatology Research44 citations Open access
Semantic Scholar
Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib
M. Rimini, M. Kudo, T. Tada, S. Shigeo +58 more
2021ESMO Open42 citations Open access
Semantic Scholar
Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients
M. Rimini, M. Persano, T. Tada, G. Suda +64 more
2023Journal of Cancer Research and Clinical Oncology39 citations Open access
Semantic Scholar
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study
A. Casadei-Gardini, M. Rimini, M. Kudo, S. Shimose +25 more
2022Liver Cancer36 citations Open access
Semantic Scholar
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy
V. Burgio, M. Iavarone, G. D. Di Costanzo, F. Marra +33 more
2021Cancer Management and Research36 citations Open access
Semantic Scholar
Cholangiocarcinoma: new perspectives for new horizons
M. Rimini, M. Puzzoni, F. Pedica, N. Silvestris +13 more
2021Expert Review of Gastroenterology & Hepatology32 citations
Semantic Scholar
Potential acceptance of COVID-19 vaccine in rheumatological patients: a monocentric comparative survey
C. Campochiaro, G. Trignani, A. Tomelleri, S. Cascinu +1 more
2021Annals of the Rheumatic Diseases32 citations
Semantic Scholar
Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study
F. Nappo, L. Fornaro, L. Pompella, S. Catanese +19 more
2023Journal of Cancer Research and Clinical Oncology28 citations Open access
Semantic Scholar
Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study
M. Persano, M. Rimini, T. Tada, G. Suda +76 more
2022Journal of Cancer Research and Clinical Oncology28 citations Open access
Semantic Scholar
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort
U. Peretti, A. Cavaliere, M. Niger, G. Tortora +27 more
2021ESMO Open27 citations Open access
Semantic Scholar
Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab
M. Persano, M. Rimini, T. Tada, G. Suda +68 more
2023Oncology26 citations Open access
Semantic Scholar
Prediction of Early Distant Recurrence in Upfront Resectable Pancreatic Adenocarcinoma: A Multidisciplinary, Machine Learning-Based Approach
D. Palumbo, M. Mori, Francesco Prato, S. Crippa +14 more
2021Cancers25 citations Open access
Semantic Scholar
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey
G. Orsi, M. Di Marco, A. Cavaliere, M. Niger +26 more
2021ESMO Open24 citations Open access
Semantic Scholar
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma
M. Rimini, C. Fabregat-Franco, V. Burgio, S. Lonardi +21 more
2022Scientific Reports22 citations Open access
Semantic Scholar
Diet and Lifestyle Habits in Early-Onset Colorectal Cancer: A Pilot Case-Control Study
M. Puzzono, A. Mannucci, M. Di Leo, R. Zuppardo +12 more
2022Digestive Diseases22 citations
Semantic Scholar
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants.
M. Macchini, Federico Centonze, U. Peretti, G. Orsi +4 more
2021Cancer Treatment Reviews22 citations
Semantic Scholar
Is Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma Superior Even to Lenvatinib? A Matching-Adjusted Indirect Comparison
A. Casadei-Gardini, T. Tada, S. Shimose, T. Kumada +3 more
2021Targeted oncology22 citations
Semantic Scholar
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib
I. Rapposelli, T. Tada, S. Shimose, V. Burgio +50 more
2021Liver international (Print)22 citations
Semantic Scholar
Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience
M. Rimini, V. Burgio, L. Antonuzzo, L. Rimassa +14 more
2023Therapeutic Advances in Medical Oncology21 citations Open access
Semantic Scholar
Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?
M. Rimini, M. Persano, T. Tada, G. Suda +66 more
2023Targeted oncology21 citations
Semantic Scholar
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma.
M. Rimini, T. Macarulla, V. Burgio, S. Lonardi +23 more
2022European Journal of Cancer20 citations Open access
Semantic Scholar
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters.
M. Rimini, Eleonora Loi, C. Fabregat-Franco, V. Burgio +23 more
2022European Journal of Cancer20 citations Open access
Semantic Scholar
Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma
I. Rapposelli, S. Shimose, T. Kumada, S. Okamura +36 more
2021ESMO Open20 citations Open access
Semantic Scholar
The role of immune checkpoint inhibitors in the treatment sequence of advanced Gastric or Gastro-esophageal Junction cancer: a Systematic Review and Meta-analysis of randomized trials.
M. Dubois, N. Liscia, O. Brunetti, P. Ziranu +7 more
2022Critical reviews in oncology/hematology19 citations
Semantic Scholar
Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma: A Focus on Oncological Outcomes
F. Ratti, A. Casadei-Gardini, F. Cipriani, G. Fiorentini +4 more
2021Journal of Clinical Medicine19 citations Open access
Semantic Scholar
ROLE OF STEREOTACTIC RADIOSURGERY FOR THE TREATMENT OF BRAIN METASTASIS IN THE ERA OF IMMUNOTHERAPY: A SYSTEMATIC REVIEW ON CURRENT EVIDENCES AND PREDICTING FACTORS.
F. Gagliardi, P. De Domenico, S. Snider, F. Roncelli +8 more
2021Critical reviews in oncology/hematology19 citations
Semantic Scholar
Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
G. Arbore, L. Albarello, Gabriele Bucci, M. Punta +16 more
2023Cancer Research18 citations Open access
Semantic Scholar
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression
P. Ziranu, V. Aimola, A. Pretta, M. Dubois +14 more
2023Cancers18 citations Open access
Semantic Scholar
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis
A. Casadei-Gardini, L. Rimassa, M. Rimini, C. Yoo +14 more
2021Journal of Cancer Research and Clinical Oncology18 citations Open access
Semantic Scholar
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer
L. Licata, G. Viale, M. Giuliano, G. Curigliano +18 more
2023npj Breast Cancer17 citations Open access
Semantic Scholar
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial.
S. Cascinu, R. Berardi, R. Bianco, D. Bilancia +21 more
2021European Journal of Cancer17 citations
Semantic Scholar
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients
M. Rimini, C. Fabregat-Franco, M. Persano, V. Burgio +22 more
2023Targeted oncology14 citations
Semantic Scholar
Evolution of Surgical Treatment of Colorectal Liver Metastases in the Real World: Single Center Experience in 1212 Cases
F. Ratti, F. Cipriani, G. Fiorentini, V. Burgio +5 more
2021Cancers14 citations Open access
Semantic Scholar
The Prognostic Value of the New Combined Hemo-Eosinophil Inflammation Index (HEI Index): A Multicenter Analysis of Anal Cancer Patients Treated with Concurrent Chemo-Radiation
M. Rimini, P. Franco, B. De Bari, M. Zampino +12 more
2021Cancers14 citations Open access
Semantic Scholar
Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice
E. Lai, S. Cascinu, M. Scartozzi
2021Frontiers in Oncology14 citations Open access
Semantic Scholar
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients
A. Casadei-Gardini, R. Filippi, M. Rimini, I. Rapposelli +22 more
2021Oncology14 citations
Semantic Scholar
Validation of the easy‐to‐use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib
M. Rimini, Wonseok Kang, V. Burgio, M. Persano +34 more
2022Hepatology Research13 citations Open access
Semantic Scholar
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis
M. Rimini, V. Burgio, L. Antonuzzo, L. Rimassa +12 more
2022Targeted oncology13 citations
Semantic Scholar
α‐FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
F. Rossari, T. Tada, G. Suda, S. Shimose +69 more
2023International Journal of Cancer12 citations Open access
Semantic Scholar
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib
M. Rimini, C. Yoo, S. Lonardi, G. Masi +16 more
2021Hepatology Research11 citations
Semantic Scholar
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery.
M. Canale, F. Foschi, P. Andreone, G. Ercolani +11 more
2021HPB10 citations Open access
Semantic Scholar
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis.
F. Ratti, R. Marino, F. Pedica, A. Gardini +7 more
2023Surgery8 citations
Semantic Scholar
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv)
G. Orsi, A. Cavaliere, G. Tortora, S. Lonardi +29 more
2022British Journal of Cancer8 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Casadei-Gardini×32
Invite
A. Casadei-Gardini — researcher profile on SciRah
M. Rimini×29
Invite
M. Rimini — researcher profile on SciRah
V. Burgio×27
Invite
V. Burgio — researcher profile on SciRah
M. Scartozzi×26
Invite
M. Scartozzi — researcher profile on SciRah

×20

Invite

S. Lonardi — researcher profile on SciRah

Invite

F. Ratti — researcher profile on SciRah

L. Aldrighetti×16

Invite

L. Aldrighetti — researcher profile on SciRah

Invite

T. Kumada — researcher profile on SciRah

Invite

C. Vivaldi — researcher profile on SciRah

Invite

T. Tada — researcher profile on SciRah

Invite

S. Shimose — researcher profile on SciRah

Invite

G. Masi — researcher profile on SciRah